Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports account for a ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

In addition to API, drugs have inactive components called excipients, whose production is also global. A tariff could apply to the final drug product or its separate components. But even if the U.S.

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...